Advances in malaria therapy in 2003;Avancees therapeutiques contre le paludisme en 2003

Medecine Tropicale

Volumn 63, Issue 3, 2003, Pages 267-270

  Danis, M ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Combination therapies; New antimalarial agents; Plasmodium falciparum malaria

Indexed keywords

AMINO 8 QUINOLINE; AMODIAQUINE; ANTIMALARIAL AGENT; ARSUCAM; ARSUDAR; ARTEMISIN; ARTEMISIN DERIVATIVE; ARTESUNATE; ARTESUNATE PLUS AMODIAQUINE; ARTESUNATE PLUS FANSIDAR; CHLOROQUINE; CLINDAMYCIN; ETAQUINE; FANSIDAR; FERROQUINE; FOSMIDOMYCIN; PHOSPHATIDYLCHOLINE INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAFENOQUINE; TRIOXANE DERIVATIVE; TRIOXAQUINE; UNCLASSIFIED DRUG;

AFRICA; CONFERENCE PAPER; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SYNTHESIS; GEOGRAPHIC DISTRIBUTION; HUMAN; MALARIA; PATHOGENESIS; PLASMODIUM FALCIPARUM; PREVALENCE; TROPICS; ANTIBIOTIC RESISTANCE; DRUG COMBINATION; REVIEW; TROPIC CLIMATE;

PLASMODIUM FALCIPARUM;

ANTIMALARIALS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HUMANS; MALARIA; TROPICAL CLIMATE;

EID: 0642337740     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. SNOW RW, CRAIG M, DEICHMANN U, MARSH K - Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Org 1999; 77: 624-640.
2. WHITE NJ, KOSTEN F, LOOAREESUWAN S et Coll - Averting a malaria disaster. Lancet 1999; 353: 1965-1967.
3. OLLIARO PL, NEVILL C, LE BRAS J et Coll - Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 1996; 348: 1196-1201.
4. RIDLEY RG - Medical needs, scientific opportunity and the drive for antimalarial drugs. Nature 2002; 415: 686-693.
5. ANONYME - Les combinaisons thérapeutiques antipaludiques. Rapport d'une consultation technique de l'OMS. 4-5 avril 2001. WHO/CDS/2001.35.40 pages.
6. DANIS M, BRICAIRE F - The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria. Fundamental Clin Pharm 2003; 17: 155-160.
7. WHITE NJ - Why is it antimalarial drug treatments do not always work? Ann Trop Med Parasitol 1998; 92: 449-458.
8. BOUCHAUD O, MONLUN E, MUANZA K et Coll - Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncom-plicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial. Am J Trop Med Hyg 2000; 63: 274-279.
9. HOGH B, CLARKE PD, CAMUS D et Coll - Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Lancet 2000; 356: 1888-1894.
10. OVERBOSCH D, SCHILTHUIS H, BIENZLE U et Coll - Atovaquone-proguanil versus mefloquine for malaria prophylaxis in non-immune travellers: results from a randomized, double-blind study. Clin Infect Dis 2001; 33: 1015-1021.
11. VAN VUGT M, BROCKMAN A, GEMPERLIB et Coll - Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob Agents Chem 1998; 42: 135-139.
12. VAN AGTMAEL M, BOUCHAUD O, MALVY D et Coll - CGP 56697 Study Group. The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France. Int J Antimicrob Agents 1999; 12: 159-169.
13. VAN VUGT M, LOOREESUWAN S, WILAIRATANA P et Coll - Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94; 545-548.
14. BROCKMAN A, PRICE RN, VAN VUGT M et Coll - Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans R Soc Trop Med Hyg 2000; 94: 537-544.
15. ADJUIK M, AGNAMEY P, BABIKER A et Coll - Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 2002; 359: 1365-1372.
16. VON SEIDLEIN L, MILLIGAN P, PINDER M et Coll - Efficacy of artesunate plus pyrimethamine-sulfadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 2000; 355: 352-357.
17. BASCO LK, SAME EKOBO A, FOUMANE NGANE V et Coll - Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine- pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroun. Bull World Health Org 2002; 80: 538-545.
18. MUTABINGWA T, NZILA A, MBERU E et Coll - Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 2001; 358: 1218-1223.
19. SULO J, CHIMPENI P, HATCHER J et Coll - Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial. Lancet 2002; 360: 1136-1143.
20. DORSEY G, NJAMA D, KAMYA MR et Coll - Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 2002; 360: 2031-2038.
21. DENIS MB, DAVIS TME, HEWITT S et Coll - Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin Infect Dis 2002; 35: 1469-1476.
22. VAN VUGT M, LEONARDI E, PHAIPUN L et Coll - Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone- proguanil. Clin Infect Dis 2002; 35: 1498-1504.
23. HALE BH, OWUSU-AGYEIS, FRYAUFF DJ et Coll - A randomised, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum. Clin Infect Dis 2003; 36: 541-549.
24. BIOT C, DELHAES L, N'DIAYE CM et Coll - Synthesis and antimalarial activity in vitro of potential metabolites of ferrochloroquine and related compounds. Biorg Med Chem 1999; 7: 2843-2847.
25. PRADINES B, TALL A, ROGIER C et Coll - In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs. Trop Med Int Health 2002; 7: 265-270.
26. COINTEAUX L, BERRIEN JF, PEYROU V et Coll - Synthesis and antimalarial activity of 2-methoxyprop-2-yl peroxydes derivatives. Bioorg Med Chem Lett 2003; 13: 75-77.
27. BINH PD, CONG LE D, NHU TV et Coll - Nga TT. The effect of 10 alpha-trifluoromethylhydroartemisinin on Plasmodium berghei infection and its toxicity in experimental animals. Trans R Soc Trop Med Hyg 2002; 96: 677-683.
28. ROBERT A, DECHY-CABARET O, CAZELLES J, MEUNIER B - From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs. Acc Chem Res 2002; 35: 167-174.
29. WENGELNIK K, VIDAL V, ANCELIN ML et Coll - A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science 2002; 295: 1311-1314.
30. MAHMOUDIN, CICERON L, FRANETICH JF et Coll - In vitro activity of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp. Antimicrob Agents Chemother 2003; 47: (sous presse).
31. MISSINOU MA, BORRMANN S, SCHINDLER A et Coll - Fosmidomycin for malaria. Lancet 2002; 360: 1941-1942.